HealthLynked Corp (HLYK) CFO receives 35,000 option grant tied to listing
Rhea-AI Filing Summary
HealthLynked Corp reported that Chief Financial Officer O'Leary George received a grant of 35,000 options to purchase common stock at an exercise price of $3.50 per share. These options vest in full upon successful approval for listing on the Nasdaq Capital Market while he serves as Interim CFO and expire on July 22, 2036. Following this award, he holds 37,612 derivative securities, including the new options and 2,612 warrants exercisable at $6.70 per share.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
O'Leary George
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Options to purchase common stock F1, F2 | 35,000 | $0.00 | $0.00 |
Holdings After Transaction:
Options to purchase common stock — 37,612 shares (Direct)
Footnotes (2)
- F1. Options vest in full upon the Issuer's successful approval for listing on the Nasdaq Capital Market while filer is actively serving as Interim Chief Financial Officer of the Issuer.
- F2. Includes options being reported hereunder plus 2,612 warrants with an exercise price of $6.70.
Key Figures
Options granted: 35,000 options
Option exercise price: $3.50 per share
Option expiration date: July 22, 2036
+3 more
6 metrics
Options granted
35,000 options
Grant of options to purchase common stock to CFO on July 22, 2026
Option exercise price
$3.50 per share
Exercise price for the 35,000 options granted to the CFO
Option expiration date
July 22, 2036
Expiration date of the 35,000 options awarded
Derivative securities after grant
37,612
Total derivative securities held after the award, including options and warrants
Warrants held
2,612 warrants
Warrants included in post-award holdings, separate from the new options
Warrant exercise price
$6.70 per share
Exercise price for the 2,612 warrants held by the CFO
Key Terms
Nasdaq Capital Market, Interim Chief Financial Officer, exercise price, warrants
4 terms
Nasdaq Capital Market regulatory
"Options vest in full upon the Issuer's successful approval for listing on the Nasdaq Capital Market"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
Interim Chief Financial Officer financial
"while filer is actively serving as Interim Chief Financial Officer of the Issuer"
An interim chief financial officer is a temporary leader responsible for managing a company's financial activities, such as budgeting, financial planning, and reporting, during a transitional period. Think of it as filling in for a key manager until a permanent replacement is found. For investors, this role is important because it ensures financial stability and clear guidance during times of change or uncertainty.
exercise price financial
"2,612 warrants with an exercise price of $6.70"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
warrants financial
"plus 2,612 warrants with an exercise price of $6.70"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did HealthLynked (HLYK) disclose in this Form 4?
HealthLynked (HLYK) disclosed that CFO O'Leary George received a grant of 35,000 stock options to purchase common shares at an exercise price of $3.50 per share. The award is reported as a derivative security acquisition with no cash purchase price.
What are the vesting conditions for the new HLYK CFO stock options?
The 35,000 options vest in full only upon the company’s successful approval for listing on the Nasdaq Capital Market, while O'Leary George is actively serving as Interim Chief Financial Officer. If these conditions are not met, the options would not vest under this provision.
What is the exercise price and expiration date of the HLYK options grant?
The granted options carry an exercise price of $3.50 per share and an expiration date of July 22, 2036. This means the CFO may purchase common stock at $3.50 per share any time before that expiration, subject to the vesting condition being satisfied.
How many derivative securities does the HLYK CFO hold after this grant?
After the grant, O'Leary George holds 37,612 derivative securities in total. This figure includes the newly granted 35,000 options plus 2,612 warrants, as specified in the filing’s footnote clarifying the post-transaction amount.
Does the HLYK CFO hold any warrants in addition to the new options?
Yes. The post-transaction total of 37,612 derivative securities includes 2,612 warrants with an exercise price of $6.70 per share. These warrants are held alongside the newly granted 35,000 options to purchase HealthLynked common stock.
Was the HealthLynked (HLYK) CFO options grant reported as a purchase or an award?
The transaction is coded as an award (code A), described as a grant or other acquisition of derivative securities. It reflects compensation in the form of stock options, not an open-market share purchase or sale by the CFO.